Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | KRT6B |
| Upstream (Parents) |
|---|
| (<<) CCNA1 → KRT6B |
| (<<) CDK6 → KRT6B |
| (<<) CHODL → KRT6B |
| (<<) CRYAB → KRT6B |
| (<<) ERBB2 → KRT6B |
| (<<) FOXC2 → KRT6B |
| (<<) FZD7 → KRT6B |
| (<<) ITGB8 → KRT6B |
| (<<) KLK10 → KRT6B |
| (<<) KRT16 → KRT6B |
| (<<) MLPH → KRT6B |
| (<<) MRAS → KRT6B |
| (<<) PIM1 → KRT6B |
| (<<) PRKCDBP → KRT6B |
| (<<) PTGS2 → KRT6B |
| (<<) ROR1 → KRT6B |
| (<<) SERPINB5 → KRT6B |
| (<<) SGK1 → KRT6B |
| (<<) SH3KBP1 → KRT6B |
| (<<) SOCS3 → KRT6B |
| (<<) SPDEF → KRT6B |
| (<<) TMEM158 → KRT6B |
| (<<) TMEM45B → KRT6B |
| (<<) VAV3 → KRT6B |
| Downstream (Children) |
|---|
| KRT6B → ARL4C (>>) |
| KRT6B → CDKN1A (>>) |
| KRT6B → CDKN2A (>>) |
| KRT6B → CEBPB (>>) |
| KRT6B → CXADR (>>) |
| KRT6B → EPHA4 (>>) |
| KRT6B → FOXQ1 (>>) |
| KRT6B → GNA15 (>>) |
| KRT6B → JAG1 (>>) |
| KRT6B → KHDRBS3 (>>) |
| KRT6B → KLK5 (>>) |
| KRT6B → KLK7 (>>) |
| KRT6B → KRT14 (>>) |
| KRT6B → KRT5 (>>) |
| KRT6B → LIF (>>) |
| KRT6B → LIPG (>>) |
| KRT6B → MMP7 (>>) |
| KRT6B → NFIA (>>) |
| KRT6B → PI3 (>>) |
| KRT6B → PLA2G4A (>>) |
| KRT6B → PLCB3 (>>) |
| KRT6B → PTPLA (>>) |
| KRT6B → RAB7B (>>) |
| KRT6B → RBP1 (>>) |
| KRT6B → RPS6KB1 (>>) |
| KRT6B → S100A2 (>>) |
| KRT6B → SERPINB2 (>>) |
| KRT6B → SFN (>>) |
| KRT6B → SLC16A6 (>>) |
| KRT6B → SLC6A14 (>>) |
| KRT6B → SMOX (>>) |
| KRT6B → TGFA (>>) |
| KRT6B → TNFRSF1A (>>) |
| KRT6B → TUBA1A (>>) |
